BioCentury
ARTICLE | Financial News

Rib-X raises $50 million

June 21, 2006 1:18 AM UTC

Rib-X (New Haven, Conn.) raised $50 million in a series C round led by Warburg Pincus. MedImmune Ventures and Radius joined existing investors ABS Ventures; Axiom Venture Partners; Cardinal Partners; EuclidSR; Oxford Bioscience Partners; and S.R. One. Rib-X's WQ-3034 has completed Phase II testing for respiratory infections. Rib-X has rights to the broad-spectrum quinolone from Wakunaga (Osaka, Japan). ...